Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

Thorax. Published Online First: 1 February 2008. doi:10.1136/thx.2007.089359
Copyright © 2008 BMJ Publishing Group Ltd & British Thoracic Society

This Article
Right arrow Full Text (Rapid PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Mackerness, K. J
Right arrow Articles by Jose, P. J
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mackerness, K. J
Right arrow Articles by Jose, P. J

Papers

Characterisation of the range of neutrophil stimulating mediators in Cystic Fibrosis sputum

Kathryn J Mackerness 1*, Gavin R Jenkins 2, Andrew Bush 3 and Peter J Jose 1

1 Imperial College London, United Kingdom
2 Durham University, United Kingdom
3 Royal Brompton Hospital, United Kingdom

* To whom correspondence should be addressed. E-mail: kathryn_mackerness{at}hotmail.com.

Accepted 23 December 2007


*   Abstract

Background: Most cystic fibrosis (CF) patients die of respiratory failure due to chronic infection and destructive neutrophilic inflammation.

Objective: To identify potential therapeutic targets by characterising the neutrophil stimulating mediators in the CF airway.

Methods: Spontaneously expectorated CF sputum was extracted in phosphate buffered saline for assays of neutrophil chemotaxis, intracellular calcium mobilisation and cell shape change. Mediators were purified by ion exchange, C18 reversed phase and size exclusion chromatography. Results: A pool of CF sputum contained considerable neutrophil stimulating activity but neutralisation of interleukin (IL)-8/CXCL8 had little inhibitory effect on neutrophil chemotactic (10149 ± 2023 migrating cells vs. 8661 ± 2597 at 62 mg sputum/ml, NS) or shape change (% FSC increase 46 ± 8 vs. 38 ± 5 at 19 mg sputum/ml, p<0.05) responses. Further, the CF sputum pool induced an elevation of intracellular calcium ions even after desensitisation of the neutrophils to IL-8. Chromatography identified contributions to the neutrophil shape change inducing activity from IL-8, other CXC chemokines, leukotriene (LT) B4 and two formyl peptides. There was also suggestive evidence for contributions from platelet activating factor (PAF) and C5a. Using non-chromatographed individual sputum samples, anti-IL-8 alone did have an inhibitory effect on neutrophil chemotaxis (median inhibition 41%, p = 0.0002). However, even in this experiment, there were clearly significantly important, non-IL-8 mediated effects of CF sputum on neutrophils and an inhibitor cocktail of anti-IL-8 plus CXCR2, LTB4, formyl peptide, PAF and C5a receptor antagonists inhibited chemotaxis by a median of 97% (p = 0.0002).

Conclusion: Many chemoattractants contribute to the neutrophil stimulating activity in CF sputum although the relative contribution of these mediators differs in different patients. The selective blockade of single mediators may not be sufficient to control neutrophil recruitment and activation in the CF airway.


Keywords: C5a, IL-8/CXCL8, LTB4, PAF, formyl peptides







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 BMJ Publishing Group Ltd & British Thoracic Society